74.30SEK-0.13%Mkt Cap: 411.78M $P/E: 13.29Today
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place…
Industry Peers
Asset ManagementKey Statistics
Company
Market Cap411.78M $
Enterprise Value395.52M $
Revenue (TTM)30.12M $
Gross Profit-152.18K $
Net Income (TTM)-38.23M $
Revenue/Share0.5202 USD
Last Price74.30 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountrySE
SectorFinancial Services
IndustryAsset Management
ISINSE0015949433
Valuation
P/E (Trailing)13.29
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue13.13
P/S13.78
P/B0.96
EPS (TTM)5.60
EPS (Forward)—
52W Range
58.9069% of range81.30
52W High81.30 SEK
52W Low58.90 SEK
Profitability
Gross Margin-31.82%
Oper. Margin98.63%
EBITDA Margin0.00%
Profit Margin-7992.94%
ROE-9.02%
ROA-9.00%
Growth
Revenue Growth-33.50%
Earnings Growth-26.40%
Cash Flow & Leverage
Operating CF-25.41M $
CapEx (TTM)—
FCF Margin71.35%
FCF Yield5.22%
Net Debt-16.26M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio27.68
Quick Ratio25.11
Book Value/Sh77.92 SEK
Cash/Share2.937 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)72.00 SEK
Upside (mean)-3.1%
Target Range72.00 SEK – 72.00 SEK
# Analysts1
Ownership
Shares Out.57.86M
Float22.11M
Insiders61.69%
Institutions25.63%
Technical
SMA 5072.21 (+2.9%)
SMA 20069.96 (+6.2%)
Beta0.70
S&P 52W Chg18.16%
Avg Vol (30d)22.58K
Avg Vol (10d)21.14K
Technical Indicators
RSI (14)55.6
MACD0.2900
MACD Signal0.3731
MACD Hist.-0.0830
BB Upper75.45 SEK
BB Middle74.06 SEK
BB Lower72.68 SEK
BB Width3.73%
ATR (14)1.554 SEK
Vol Ratio (20d)0.77x